Shandong Luoxin Pharmaceutical Group Stock Co Ltd ADR (Sponsored)


By |


Shandong Luoxin Pharmaceutical Group Stock Co Ltd along with its subsidiaries is engaged in the manufacturing and selling of pharmaceutical products. It is involved in the research and development of LXI-15028, a potassium-competitive acid blocker, which is in phase III development for the treatment of reflux esophagitis and other acid-related gastrointestinal diseases; and LXI-15029, an ATP mTOR kinase inhibitor that acts as potent and selective dual inhibitors of mTORC1 and mTORC2 that controls the process of tumor formation and growth. The company mainly operates in the People's Republic of China.

Contact Information

Main Phone: +86 5398241226
Address: Luo seven Road
Address 2: China National Hi-Industial Development Zone
State: Shandong
City / Town: Linyi
Country: CHN
Postal Code: 276017

Issuer Information

Exchange: OTO
Employees: 165
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 11.00 52 Wk Low 11.00
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 60,960,000.00 EPS (TTM) 9.85 PE Ratio 1.10 Exchange OTCPK